It focuses on producing of surfactant replacement therapies for patients with respiratory disease and neonatology for the improvement of respiratory distress syndrome for infants.
Windtree Therapeutics. Windtree therapeutics has 32 employees at their 1 location and $198 k in annual revenue in fy 2019. It focuses on producing of surfactant replacement therapies for patients with respiratory disease and neonatology for the improvement of respiratory distress syndrome for infants. Contact windtree therapeutics on messenger. Stock analysis for windtree therapeutics inc (wint:nasdaq cm) including stock price, stock chart, company news, key statistics, fundamentals and company profile. See more of windtree therapeutics on facebook. See insights on windtree therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at craft. Engages in the manufacture and development of products for infants and respiratory diseases. Windtree proprietary technology platform includes a synthetic. Windtree therapeutics, inc., a biotechnology and medical device company, engages in the research and development of products that focus on acute pulmonary and cardiovascular diseases. Engages in the manufacture and development of products for infants and respiratory diseases. The windtree therapeutics inc equities center is a collection of modules for windtree therapeutics equity research and analysis. Windtree's lead product candidate is aerosurf®, a novel, investigational drug/device product that combines the company's proprietary kl4 surfactant and aerosolization technologies. It focuses on producing of surfactant replacement therapies for patients with respiratory disease and neonatology for the improvement of respiratory distress syndrome for infants. Should you invest in windtree therapeutics (nasdaqcm:wint)? Windtree therapeutics, inc., a biotechnology and medical device company, engages in the research and development of products that focus on acute pulmonary and cardiovascular diseases.
Management - Windtree Therapeutics, Inc.. Windtree's lead product candidate is aerosurf®, a novel, investigational drug/device product that combines the company's proprietary kl4 surfactant and aerosolization technologies. It focuses on producing of surfactant replacement therapies for patients with respiratory disease and neonatology for the improvement of respiratory distress syndrome for infants. The windtree therapeutics inc equities center is a collection of modules for windtree therapeutics equity research and analysis. Windtree therapeutics has 32 employees at their 1 location and $198 k in annual revenue in fy 2019. See insights on windtree therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at craft. Stock analysis for windtree therapeutics inc (wint:nasdaq cm) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Contact windtree therapeutics on messenger. See more of windtree therapeutics on facebook. Windtree therapeutics, inc., a biotechnology and medical device company, engages in the research and development of products that focus on acute pulmonary and cardiovascular diseases. Engages in the manufacture and development of products for infants and respiratory diseases. Windtree proprietary technology platform includes a synthetic. Should you invest in windtree therapeutics (nasdaqcm:wint)? It focuses on producing of surfactant replacement therapies for patients with respiratory disease and neonatology for the improvement of respiratory distress syndrome for infants. Windtree therapeutics, inc., a biotechnology and medical device company, engages in the research and development of products that focus on acute pulmonary and cardiovascular diseases. Engages in the manufacture and development of products for infants and respiratory diseases.
Windtreetx.com | Windtree Therapeutics, Inc. from windtreetx.com
Windtree therapeutics, inc., a biotechnology and medical device company, engages in the research and development of products that focus on acute pulmonary and cardiovascular diseases. According to our live forecast system, windtree therapeutics, inc. Windtree proprietary technology platform includes a synthetic. It focuses on producing of surfactant replacement therapies for patients with respiratory disease and neonatology for the improvement of respiratory distress syndrome for infants. The windtree therapeutics inc equities center is a collection of modules for windtree therapeutics equity research and analysis. No news for in the past two years. Researching windtree therapeutics (otcmkts:wint) stock?
It focuses on producing of surfactant replacement therapies for patients with respiratory disease and neonatology for the improvement of respiratory distress syndrome for infants.
Researching windtree therapeutics (otcmkts:wint) stock? The company is focused on developing kl4 surfactant therapies for. Windtree's lead product candidate is aerosurf®, a novel, investigational drug/device product that combines the company's proprietary kl4 surfactant and aerosolization technologies. View the latest windtree therapeutics inc. See more of windtree therapeutics on facebook. Windtree proprietary technology platform includes a synthetic. Researching windtree therapeutics (otcmkts:wint) stock? Windtree therapeutics, inc., a biotechnology and medical device company, engages in the research and development of products that focus on acute pulmonary and cardiovascular diseases. It focuses on producing of surfactant replacement therapies for patients with respiratory disease and neonatology for the improvement of respiratory distress syndrome for infants. Stock quote, stock chart, quotes, analysis, advice, financials and news for share windtree therapeutics, inc., formerly discovery laboratories, inc., is a biotechnology company. Wint), a biotechnology and medical device company focused on developing drug product candidates and medical device technologies to address acute cardiovascular and pulmonary diseases. According to our live forecast system, windtree therapeutics, inc. Wint stock predictions are updated every 5 minutes with latest exchange prices by smart technical market. Should you invest in windtree therapeutics (nasdaqcm:wint)? No news for in the past two years. Windtree therapeutics stock price forecast, wint stock price prediction. Windtree therapeutics inc (wint) financial statements (2020 and earlier). It focuses on producing of surfactant replacement therapies for patients with respiratory disease and neonatology for the improvement of respiratory distress syndrome for infants. Wint investment & stock information. Stock analysis for windtree therapeutics inc (wint:nasdaq cm) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Is a biotechnology company focused on developing novel surfactant therapies for respiratory diseases and other potential applications. Wint), a biotechnology and medical device company focused on developing drug product candidates and. It focuses on producing of surfactant replacement therapies for patients with respiratory disease and neonatology for the improvement of respiratory distress syndrome for infants. The windtree therapeutics inc equities center is a collection of modules for windtree therapeutics equity research and analysis. (wint) stock price, news, historical charts, analyst ratings and financial information from wsj. Engages in the manufacture and development of products for infants and respiratory diseases. Contact windtree therapeutics on messenger. Engages in the manufacture and development of products for infants and respiratory diseases. Windtree therapeutics has 32 employees at their 1 location and $198 k in annual revenue in fy 2019. See insights on windtree therapeutics including office locations, competitors, revenue, financials, executives, subsidiaries and more at craft. Was incorporated in 1992 and is headquartered in warrington, pennsylvania.
Windtree Therapeutics . Is A Biotechnology Company Focused On Developing Novel Surfactant Therapies For Respiratory Diseases And Other Potential Applications.
Windtree Therapeutics . Should You Invest In Windtree Therapeutics (Nasdaqcm:wint)?
Windtree Therapeutics - See Insights On Windtree Therapeutics Including Office Locations, Competitors, Revenue, Financials, Executives, Subsidiaries And More At Craft.
Windtree Therapeutics - It Focuses On Producing Of Surfactant Replacement Therapies For Patients With Respiratory Disease And Neonatology For The Improvement Of Respiratory Distress Syndrome For Infants.
Windtree Therapeutics . It Focuses On Producing Of Surfactant Replacement Therapies For Patients With Respiratory Disease And Neonatology For The Improvement Of Respiratory Distress Syndrome For Infants.
Windtree Therapeutics : Windtree Therapeutics, Inc., A Biotechnology And Medical Device Company, Engages In The Research And Development Of Products That Focus On Acute Pulmonary And Cardiovascular Diseases.
